Details
Stereochemistry | ACHIRAL |
Molecular Formula | C40H56O2 |
Molecular Weight | 568.8714 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 9 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(\C=C\C=C(C)\C=C\C1=C(C)C[C@H](O)CC1(C)C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)C[C@@H](O)CC2(C)C
InChI
InChIKey=JKQXZKUSFCKOGQ-YOPUJPICSA-N
InChI=1S/C40H56O2/c1-29(17-13-19-31(3)21-23-37-33(5)25-35(41)27-39(37,7)8)15-11-12-16-30(2)18-14-20-32(4)22-24-38-34(6)26-36(42)28-40(38,9)10/h11-24,35-36,41-42H,25-28H2,1-10H3/b12-11+,17-13+,18-14+,23-21+,24-22+,29-15+,30-16+,31-19+,32-20+/t35-,36+
Molecular Formula | C40H56O2 |
Molecular Weight | 568.8714 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 9 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/8491553Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/25976647
https://www.ncbi.nlm.nih.gov/pubmed/23703634
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8491553
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/25976647
https://www.ncbi.nlm.nih.gov/pubmed/23703634
The carotenoids lutein (L), zeaxanthin (Z), and meso-zeaxanthin (MZ) accumulate in the central retina, where they are collectively known as macular pigment (MP). Each of these three compounds exhibit a regional dominance, with MZ, Z, and L being the dominant carotenoids at the epicenter, mid-periphery, and periphery of the macula, respectively. Meso-zeaxanthin is formed directly in the retina from lutein. MZ has potent anti-inflammatory effect, which can be due to its down-regulated expression of various inflammatory mediator genes. Meso-zeaxanthin was also found to scavenge superoxide radicals, hydroxyl radicals. MZ is a part of formulation for MacuShield, which is now the UK’s most recommended eye supplement. Also exists experiments supporting that LMZ3 (meso-zeaxanthin, lutein, zeaxanthin) supplements may stabilize vision and improve the cavitation’s in patients with macular telangiectasia type 2.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25976647
take one capsule daily with a meal. One capsule contains: meso-zeaxanthin, lutein, zeaxanthin
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21338235
The concentration of meso-zeaxanthin needed for 50 % inhibition of CYP1A2 (7-methoxyresorufin-O-demethylase) was 5 µg/ml, for CYP2B 1/2 (7- pentoxyresorufin-O-depentylase) was 8 µg/ml and for CYP1A1 (7-ethoxyresorufin-O-deethylase) was 12 µg/ml, while that of CYP 2E1 (aniline hydroxylase) was 7µg/ml and for CYP 1A, 2A, 2B, 2D and 3A (aminopyrene-N-demethylase) was 10.5 µg/ml.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 11:20:05 GMT 2023
by
admin
on
Sat Dec 16 11:20:05 GMT 2023
|
Record UNII |
3O63K300I5
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB182514
Created by
admin on Sat Dec 16 11:20:05 GMT 2023 , Edited by admin on Sat Dec 16 11:20:05 GMT 2023
|
PRIMARY | |||
|
31272-50-1
Created by
admin on Sat Dec 16 11:20:05 GMT 2023 , Edited by admin on Sat Dec 16 11:20:05 GMT 2023
|
PRIMARY | |||
|
550
Created by
admin on Sat Dec 16 11:20:05 GMT 2023 , Edited by admin on Sat Dec 16 11:20:05 GMT 2023
|
PRIMARY | |||
|
3O63K300I5
Created by
admin on Sat Dec 16 11:20:05 GMT 2023 , Edited by admin on Sat Dec 16 11:20:05 GMT 2023
|
PRIMARY | |||
|
138919
Created by
admin on Sat Dec 16 11:20:05 GMT 2023 , Edited by admin on Sat Dec 16 11:20:05 GMT 2023
|
PRIMARY | |||
|
1733119
Created by
admin on Sat Dec 16 11:20:05 GMT 2023 , Edited by admin on Sat Dec 16 11:20:05 GMT 2023
|
PRIMARY | |||
|
3O63K300I5
Created by
admin on Sat Dec 16 11:20:05 GMT 2023 , Edited by admin on Sat Dec 16 11:20:05 GMT 2023
|
PRIMARY | |||
|
2531030
Created by
admin on Sat Dec 16 11:20:05 GMT 2023 , Edited by admin on Sat Dec 16 11:20:05 GMT 2023
|
PRIMARY | |||
|
100000168973
Created by
admin on Sat Dec 16 11:20:05 GMT 2023 , Edited by admin on Sat Dec 16 11:20:05 GMT 2023
|
PRIMARY | |||
|
meso-Zeaxanthin
Created by
admin on Sat Dec 16 11:20:05 GMT 2023 , Edited by admin on Sat Dec 16 11:20:05 GMT 2023
|
PRIMARY | |||
|
481
Created by
admin on Sat Dec 16 11:20:05 GMT 2023 , Edited by admin on Sat Dec 16 11:20:05 GMT 2023
|
PRIMARY | |||
|
6442658
Created by
admin on Sat Dec 16 11:20:05 GMT 2023 , Edited by admin on Sat Dec 16 11:20:05 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
CONSTITUENT MAY BE PRESENT -> PARENT |
USP
|
||
|
CONSTITUENT MAY BE PRESENT -> PARENT |
9.0% total carotenoid content
USP
|
||
|
CONSTITUENT MAY BE PRESENT -> PARENT |
USP
|